Doris Burke

Senior Research Reporter

Photo of Doris Burke

Doris Burke is senior research reporter. Prior to joining ProPublica in 2019, she was a researcher at the New York Times working on investigative and daily stories. While at Fortune Magazine, she collaborated on award winning financial crime stories. Before moving to journalism, she was research librarian at several investment banks. She has a history degree from St. Bonaventure University and library science degree from Pratt Institute.

Chinese Organized Crime’s Latest U.S. Target: Gift Cards

Chinese crime rings already dominate the illegal marijuana trade in the U.S. and launder cocaine and heroin profits. Now a federal task force is investigating their role in a burgeoning form of gift card fraud.

Walmart Bought a Finance App and Reduced Fraud Protections. Guess What Happened Next?

The retail giant has long sought to become a financial powerhouse. But after it acquired a neobank called One in 2022, fraud complaints multiplied and customer reviews cratered.

How Walmart’s Financial Services Became a Fraud Magnet

Scammers have duped consumers out of more than $1 billion by exploiting Walmart’s lax security. The company has resisted taking responsibility while breaking promises to regulators and skimping on training.

Doctors With Histories of Big Malpractice Settlements Work for Insurers, Deciding If They’ll Pay for Care

Doctors working for health insurers can rule on 10,000 or more requests for care a year. At least a dozen were hired by major insurance companies after being disciplined by state medical boards or making multiple or outsized malpractice payments.

How a Maine Businessman Made the AR-15 Into America’s Best-Selling Rifle

Neither a gun enthusiast nor a right-wing ideologue, Richard Dyke used political connections and lobster giveaways to build Bushmaster, the company that popularized assault-style rifles.

Health Insurers Have Been Breaking State Laws for Years

States have passed hundreds of laws to protect people from wrongful insurance denials. Yet from emergency services to fertility preservation, insurers still say no.

The Biotech Edge: How Executives and Well-Connected Investors Make Exquisitely Timed Trades in Health Care Stocks

Secret IRS records reveal dozens of highly fortuitous biotech and health care trades. One executive bought shares in a corporate partner just before a sale, and an investor traded options right before a company’s revenues took off, netting millions.

The FCC Is Supposed to Protect the Environment. It Doesn’t.

The agency is mandated to safeguard the environment from damage caused by communication infrastructure. But when companies want to add new cell phone towers, build on protected land or launch satellites, the agency typically does little or nothing.

How Cigna Saves Millions by Having Its Doctors Reject Claims Without Reading Them

Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company doctor said.

Wealthy Executives Make Millions Trading Competitors’ Stock With Remarkable Timing

Never-before-seen IRS records show that CEOs are sometimes making multimillion-dollar bets on the stocks of direct competitors and partners — and doing so with exquisite timing.

UnitedHealthcare Tried to Deny Coverage to a Chronically Ill Patient. He Fought Back, Exposing the Insurer’s Inner Workings.

After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden procedures for rejecting claims.

U.S. Investigators Uncovered Alleged Corruption by Mexico’s Former Security Minister Years Before He Was Indicted

In what may prove to be one of the more remarkable intelligence failures of the drug war, the U.S. missed warnings that Genaro García Luna, the chief architect of Mexico’s fight against organized crime, could be in league with the criminals.

Inside Google’s Quest to Digitize Troops’ Tissue Samples

The tech giant has long sought access to a priceless trove of veterans’ skin samples, tumor biopsies and slices of organs. DOD staffers have pushed back, raising ethical and legal concerns, but Google might win anyway.

She Wanted an Abortion. A Judge Said She Wasn’t Mature Enough to Decide.

As abortion access dwindles, America’s “parental-involvement” laws place further restrictions on teenagers — who may need to ask judges for permission to end their pregnancies.

Endgame: How the Visionary Hospice Movement Became a For-Profit Hustle

Half of all Americans now die in hospice care. Easy money and a lack of regulation transformed a crusade to provide death with dignity into an industry rife with fraud and exploitation.

How the FCC Shields Cellphone Companies From Safety Concerns

The wireless industry is rolling out thousands of new transmitters amid a growing body of research that calls cellphone safety into question. Federal regulators say there’s nothing to worry about — even as they rely on standards established in 1996.

That Cardboard Box in Your Home Is Fueling Election Denial

A previously unreported boom in profits for the shipping supply giant Uline has provided the funds for a deeply conservative Midwestern family to bankroll anti-democracy causes around the country.

Rent Going Up? One Company’s Algorithm Could Be Why.

Texas-based RealPage’s YieldStar software helps landlords set prices for apartments across the U.S. With rents soaring, critics are concerned that the company’s proprietary algorithm is hurting competition.

Barbados Resists Climate Colonialism in an Effort to Survive the Costs of Global Warming

Across the Caribbean, soaring national debt is a hidden but decisive aspect of the climate crisis, hobbling countries’ ability to protect themselves from disaster. One island’s leader is fighting to find a way out.

Meet the Billionaire and Rising GOP Mega-Donor Who’s Gaming the Tax System

Susquehanna founder and TikTok investor Jeff Yass has avoided $1 billion in taxes while largely escaping public scrutiny. He’s now pouring his money into campaigns to cut taxes and support election deniers.

Follow ProPublica

Latest Stories from ProPublica